| Known as |
flupirtine |
ClinicalTrials.gov intervention name — accepted as the source's own label NCT01676246 ↗3NCT06971250 ↗ NCT00623415 ↗ NCT01450865 ↗
|
| Known as |
brand names: Trancopal Dolo, Katadolon |
“brand names: Trancopal Dolo, Katadolon” NCT01450865 ↗
|
| Known as |
D-9998 |
ChEMBL registry synonym — accepted as the source's own label CHEMBL255044 ↗
|
| Known as |
Flupirtina |
ChEMBL registry synonym — accepted as the source's own label CHEMBL255044 ↗
|
| Known as |
FLUPIRTINE MALEATE |
ChEMBL registry synonym — accepted as the source's own label CHEMBL255044 ↗
|
| Known as |
Flupirtinte |
ChEMBL registry synonym — accepted as the source's own label CHEMBL255044 ↗
|
| Known as |
Flupirtinte maleate |
ChEMBL registry synonym — accepted as the source's own label CHEMBL255044 ↗
|
| Known as |
Kadadolon inject |
“Administration of 100 mg flupirtine intravenous (3 mg solution intravenously, 1 vial Kadadolon® inject)” NCT01676246 ↗
|
| Known as |
Kadadolon S long retard tablet |
“Administration of 400 mg flupirtine (1 Kadadolon® S long retard tablet)” NCT01676246 ↗
|
| Known as |
W-2964 |
ChEMBL registry synonym — accepted as the source's own label CHEMBL255044 ↗
|
| Known as |
W-2964M |
ChEMBL registry synonym — accepted as the source's own label CHEMBL255044 ↗
|
| Action |
Activate |
“activates Kv7 potassium channels” PMID 23394517 ↗ Feb 2013
|
| Modality |
Small molecule |
— CHEMBL255044 ↗
|
| Route |
Oral |
“given twice daily as an oral medication” NCT00623415 ↗
|